Skip to content

Efficacy of High Flow Nasal Cannula Oxygen to Reduce Desaturation During Tracheal Intubation

High Flow Nasal Cannula Oxygen for Pre and During Procedure Oxygenation During Tracheal Intubation: Comparison With High FiO2 Non Rebreathing Bag Reservoir Facemasks

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01699880
Acronym
HAPI
Enrollment
101
Registered
2012-10-04
Start date
2011-03-31
Completion date
2013-01-31
Last updated
2014-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Need for Intubation, Oxygenation Before and During Intubation

Keywords

tracheal intubation, preoxygenation, desaturation, hypoxemia, oxygen therapy, high flow nasal cannula oxygen therapy

Brief summary

Tracheal intubation of critically ill patients is associated in the intensive care unit (ICU) with significant complications and morbidity. Patient desaturation is one of the most common complications that may lead to cardiac arrest despite pre-intubation oxygenation. Preoxygenation can be improved by the use of non-invasive ventilation, but this technique can be cumbersome to implement in the context of urgent intubation and more importantly it does not insure oxygenation during intubation. High flow nasal cannula oxygen therapy is a technique that has been shown to improve patient oxygenation in the context of acute hypoxemic respiratory failure. It bears the potential to be of clinical benefit in the setting of tracheal intubation in the ICU to ensure patient safety. The purpose of this study is to compare pre- and per-intubation (during intubation) oxygenation with either a conventional high FiO2 oxygen bag reservoir facemask (current standard practice) or high flow nasal cannula oxygen therapy (new practice to be implemented in our ICU).

Detailed description

Pre-oxygenation is ensured in our ICU with a high FiO2 nonrebreathing facemask, except in patients already under high flow nasal cannula oxygen therapy because of acute hypoxemic respiratory failure. A nasal catheter is positioned to ensure a low oxygen flow during laryngoscopy. Whether or not all patients should benefit from high flow nasal cannula oxygen therapy for pre-oxygenation remains unknown. In order to improve quality of care delivered to our patients and in anticipation of a change in our practice, we decided to record prospectively oxygen parameters during and immediately of intubation using a facemask and to compare them with parameters obtained in patients intubated after our change in practice. The change of practice consists in the systematic use of high flow nasal cannula oxygen therapy to ensure pre and during procedure (tracheal intubation)oxygenation.

Interventions

None listed

Sponsors

Hôpital Louis Mourier
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ICU patient requiring tracheal intubation

Exclusion criteria

* age \< 18 years * cardiac arrest * acute respiratory failure requiring immediate high flow nasal cannula oxygen, defined as patient with SpO2 \< 95% while under 15 L:min oxygen with a nonrebreathing facemask

Design outcomes

Primary

MeasureTime frame
pulse oxymetry after preoxygenation3min prexoxygenation
lowest pulse oxymetry (SpO2) during intubationfrom beginning of laryngoscopy to completed intubation
mean pulse oxymetry during intubationfrom beginning of laryngoscopy to completed intubation
pulse oxymetry after intubationat connection of the patient to the ventilator

Secondary

MeasureTime frame
number of pulse oxymetry below 80%from laryngoscopy to 30 minutes once tracheal intubation completed
mean pulse oxymetryone, five and thirty minutes after intubation
number of pulse oxymetry below 90%from laryngoscopy to 30 minutes once tracheal intubation completed

Other

MeasureTime frame
hemodynamic instability defined as arterial systolic blood pressure below 80 mmHgduring and immediately after procedure
cardiac arrestduring and immediately after procedure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026